Skip to content
Home/Companies/MedTech/Optomed
Optomed

Optomed

MedTech·Finland·Exited 2019·Held 4yr
Entry
2015
Hold
4yr
Exit
2019

Who owns Optomed?

Optomed was owned by Bosch Ventures through Robert Bosch Venture Capital Fund III (2016 vintage) from 2015 to 2019, exited via IPO.

Hand-verified · updated 2026-07-16

Bosch Ventures
Investor
Bosch Ventures
Robert Bosch Venture Capital Fund III · 2016 · VC

Key facts

HQFinland
SectorMedTech
StatusAcquired
Websitewww.optomed.com
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2019

More from Robert Bosch Venture Capital Fund III

Other portfolio companies in the same fund.

Syntiant
Syntiant
Active
Deep TechUnited States· 2018
Xometry
Xometry
Exited 2021
IndustrialsUnited States· 2018
Zapata Computing
Exited 2024
SoftwareUnited States· 2018
Actility
Actility
Exited 2026
TelecomFrance· 2017
to
ClearML
Active
SoftwareIsrael· 2017
AIRY3D
Airy3d
Active
Deep TechCanada· 2016

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Optos
Exited 2015
Amadeus Capital PartnersUK
to
Axomove
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Clee Medical
Clee Medical
Active
High-Tech Gruenderfonds (HTGF)Switzerland· 2026
CollimateHealth
Active
Caesar Ventures ManagementGermany· 2026
Track Optomed

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Optomed.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue